Pharmafile Logo

Peter Impey

- PMLiVE

Right intervention, right tool

'Don't start with the solution, start with the problem'

- PMLiVE

GSK buys cancer firm Tesaro for $5.1bn

Acquisition re-establishes US commercial operations in oncology

- PMLiVE

Digital applications are transforming the market access landscape

Optimising product value through digital technology

- PMLiVE

Amgen’s BCMA drug on course to challenge CAR-Ts in myeloma

BiTE will rival therapies from Bluebird, Celgene/Juno, J&J/Legend biotech

- PMLiVE

Grail to initiate largest ever UK cancer screening study

Will start testing on 50,000 people in early 2019

- PMLiVE

New models of NHS care – new models of pharma response?

At PME and IQVIA’s roundtable event, leaders discuss how industry needs to adapt to help an NHS undergoing transformational change

- PMLiVE

Video – The importance of efficient ideas

With the right idea, video is a powerful tool within any industry, with the wrong idea it can become a time-consuming money sponge. An efficient idea is a must.

Page & Page Health

- PMLiVE

Regeneron’s early stage bispecific shows promise

Bispecifics and antibody drug conjugates will challenge CAR-Ts

Celgene building

ASH18: CAR-T and drugs give new options for multiple myeloma

San Diego congress showcasing data in important haematology markets

- PMLiVE

FDA fast tracks Novartis’ SMA gene therapy

Gene therapy could be approved in first half of 2019, will challenge Biogen's Spinraza

- PMLiVE

Porterhouse celebrates 12 months of smarter insight-driven medical communications

Strategic scientific and medical communications agency, Porterhouse Medical Group, is celebrating the first birthday of Porterhouse Insights, its global research, insight and evidence consultancy.

Porterhouse Medical Group

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links